Back

A phase I clinical trial assessing prophylactic infusion of donor CD45RA-negative memory - effector T cells into patients transplanted with hematopoietic stem cells from haploidentical donors after reduced intensity conditioning

This “allocated fund” from the Symphasis charitable umbrella foundation was awarded to Dr. Anne-Claire Mamez from the Geneva University Hospitals in April 2018.

Summary of the research plan

News & Events

Posted on
The protein behind immunotherapy resistance

A study led by Professors Hanahan, Zeng, Saghafinia and Chryplewicz has uncovered a protein overexpressed in numerous cancer types that suppresses the…

Read more
Posted on
Annual conference of the ISREC Foundation

We were very honored to welcome Federal Councilor Guy Parmelin to our annual conference on the challenges in cancer research.

This event was a great…

Read more
Posted on
Prof. Elisa Oricchio, new Director of the ISREC@epfl Institute

Congratulations to Prof. Elisa Oricchio – ISREC Foundation Chair in Translational Oncology from 2014 to 2020 – appointed Director of the ISREC…

Read more
Posted on
Our director, Prof. Susan M. Gasser, is the recipient of an honorary doctorate of the University of Geneva

In recognition of her exceptional commitment to scientific research, Prof. Susan M. Gasser, director of the ISREC Foundation, received an honorary…

Read more
See all the news
© 2015 Fondation ISREC   |   Droits réservés